ascendis pharma glp-1 receptor agonists weight management diabetes treatments Novo pens $285M biobucks deal to use Ascendis' tech to create monthly agonist Glucagon-Like Peptide-1 Based Therapies: A
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15























